EMCURE PHARMACEUTICALS
Back to All Ratios
|
EMCURE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 13.55 | 1.57 | 1.55 | 1.40 | 1.55 |
What is the latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2025 | 13.55 |
| Mar2024 | 1.57 |
| Mar2023 | 1.55 |
| Mar2022 | 1.40 |
| Mar2021 | 1.55 |
How is EV/Core EBITDA of EMCURE PHARMACEUTICALS Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 13.55 | 763.06 | |
| Mar2024 | 1.57 | 1.29 | |
| Mar2023 | 1.55 | 10.71 | |
| Mar2022 | 1.4 | -9.68 | |
| Mar2021 | 1.55 | - | |
Other Financial Ratios of EMCURE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹32,692.9 Cr | 2.4% | 2.3% | 26.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 2.4% |
2.3% |
26.9% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses